Crossmark

Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats

Crossref DOI link: https://doi.org/10.1016/j.jsps.2022.03.005

Published Print: 2022-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ahmed, Sanaa

El-Sayed, Mahmoud M.

Kandeil, Mohamed A.

Khalaf, Marwa M.
License Information

Text and Data Mining valid from 2022-06-01

Text and Data Mining valid from 2022-06-01

Version of Record valid from 2022-03-10
More Information

This article is maintained by: Elsevier

Article Title: Empagliflozin attenuates neurodegeneration through antioxidant, anti-inflammatory, and modulation of α-synuclein and Parkin levels in rotenone-induced Parkinson’s disease in rats

Journal Title: Saudi Pharmaceutical Journal

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jsps.2022.03.005

Content Type: article

Copyright: © 2022 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.

Document is current

Any future updates will be listed below